LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Relative Growth Rate After Treatment
SK-BR-3 TGX221
10.0
uM
LJP5
 72
hr
 2543 5492 5578 0.9846 0.9717
SK-BR-3 Torin1
10.0
uM
LJP6
 72
hr
 2543 1414 5578 0.2535 -0.3720
SK-BR-3 Torin2
10.0
uM
LJP5
 72
hr
 2543 1112 5578 0.1993 -0.4716
SK-BR-3 Tozasertib
10.0
uM
LJP5
 72
hr
 2543 2168 5578 0.3886 -0.1237
SK-BR-3 Trametinib
10.0
uM
LJP5
 72
hr
 2543 4383 5578 0.7857 0.6061
SK-BR-3 TWS119
10.0
uM
LJP5
 72
hr
 2543 1147 5578 0.2056 -0.4601
SK-BR-3 Vemurafenib
10.0
uM
LJP5
 72
hr
 2543 5192 5578 0.9307 0.8726
SK-BR-3 Withaferin A
10.0
uM
LJP5
 72
hr
 2543 1381 5578 0.2477 -0.3828
SK-BR-3 Withaferin A
10.0
uM
LJP6
 72
hr
 2543 1423 5578 0.2552 -0.3689
SK-BR-3 WYE-125132
10.0
uM
LJP6
 72
hr
 2543 1916 5578 0.3436 -0.2065
SK-BR-3 WZ3105
10.0
uM
LJP5
 72
hr
 2543 1308 5578 0.2345 -0.4070
SK-BR-3 XMD11-50
10.0
uM
LJP6
 72
hr
 2543 2193 5578 0.3932 -0.1154
SK-BR-3 Y39983
10.0
uM
LJP6
 72
hr
 2543 1725 5578 0.3093 -0.2695
SK-BR-3 YM 201636
10.0
uM
LJP5
 72
hr
 2543 3011 5578 0.5399 0.1543
SK-BR-3 ZSTK474
10.0
uM
LJP6
 72
hr
 2543 2048 5578 0.3671 -0.1632